Grifols SA responded to false allegations from Gotham City Research about accounting practices related to its acquisitions of Haema AG and Biotest US Corporation, which were completed in 2018 for a total of $538 million. The company confirmed its management of these entities and denied any issues raised, affirming that all transactions are transparent and recorded properly.